IP41-15: Clinical outcomes of neoadjuvant chemotherapy–guided bladder preservation in muscle-invasive bladder cancer: Long-term results of a phase II trial.
Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
147A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!